Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes

Br J Haematol. 2005 Sep;130(5):797-9. doi: 10.1111/j.1365-2141.2005.05682.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antigens, CD19 / analysis
  • Antigens, CD34 / analysis
  • B-Lymphocytes / enzymology
  • Biomarkers / analysis
  • CD3 Complex / analysis
  • Cell Differentiation
  • Cell Proliferation
  • DNA Mutational Analysis
  • Granulocytes / enzymology*
  • Homozygote
  • Humans
  • Janus Kinase 2
  • Myeloproliferative Disorders / enzymology
  • Myeloproliferative Disorders / genetics*
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*
  • T-Lymphocytes / enzymology

Substances

  • Antigens, CD19
  • Antigens, CD34
  • Biomarkers
  • CD3 Complex
  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2